A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

Clinical trial NCT07541287 · RECRUITING

Trial details

NCT number: NCT07541287
Sponsor: Jade Biosciences, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

IgA Nephropathy

Start date: 2026-05-19
Primary completion: 2029-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.